Icaritin as secondary metabolites of bone-strengthening herb Epimedium, dose-dependently prevents estrogen-depletion-induced bone loss in ovariectomized rats

被引:0
|
作者
He, Yixin
Zhang, Ge [1 ]
Wang, Xinluan [1 ]
Guo, Baosheng [1 ]
Xie, Xinhui [1 ]
Hung, Leungkim [1 ]
Qin, Ling [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S358 / S358
页数:1
相关论文
共 4 条
  • [1] Icaritin as secondary metabolites of bone-strengthening herb epimedium dose-dependently prevents estrogen depletion-induced bone loss in ovariectomized rats
    He, Yixin
    Zhang, Ge
    Wang, Xinluan
    Guo, Baosheng
    Xie, Xinhui
    Hung, Leungkim
    Qin, Ling
    BONE, 2010, 47 : S404 - S405
  • [2] The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats
    Goss, PE
    Qi, SL
    Cheung, AM
    Hu, HQ
    Mendes, M
    Pritzker, KPH
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 92 (1-2): : 79 - 87
  • [3] Short-Term Prophylaxis against Estrogen Depletion-Induced Bone Loss with Calcitriol does not Provide Long-Term Beneficial Effects on Cancellous Bone Mass or Structure in Ovariectomized Rats
    R.G. Erben
    S. Bromm
    M. Stangassinger
    Osteoporosis International, 1998, 8 : 82 - 91
  • [4] Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats
    Erben, RG
    Bromm, S
    Stangassinger, M
    OSTEOPOROSIS INTERNATIONAL, 1998, 8 (01) : 82 - 91